Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 11 studies | 27% ± 11% | |
fibroblast | 10 studies | 24% ± 5% | |
glutamatergic neuron | 9 studies | 48% ± 26% | |
astrocyte | 8 studies | 33% ± 17% | |
smooth muscle cell | 8 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 7 studies | 25% ± 9% | |
ciliated cell | 7 studies | 29% ± 12% | |
GABAergic neuron | 7 studies | 47% ± 23% | |
interneuron | 6 studies | 41% ± 21% | |
adipocyte | 6 studies | 20% ± 5% | |
neuron | 5 studies | 40% ± 22% | |
microglial cell | 5 studies | 21% ± 5% | |
epithelial cell | 5 studies | 25% ± 10% | |
endothelial cell of lymphatic vessel | 5 studies | 21% ± 5% | |
pericyte | 5 studies | 27% ± 9% | |
type I pneumocyte | 5 studies | 25% ± 7% | |
type II pneumocyte | 5 studies | 26% ± 7% | |
plasmacytoid dendritic cell | 5 studies | 23% ± 5% | |
macrophage | 4 studies | 24% ± 9% | |
retinal rod cell | 4 studies | 24% ± 3% | |
club cell | 4 studies | 25% ± 10% | |
basal cell | 4 studies | 28% ± 13% | |
oligodendrocyte | 4 studies | 29% ± 15% | |
GABAergic interneuron | 3 studies | 26% ± 1% | |
granule cell | 3 studies | 24% ± 4% | |
hepatocyte | 3 studies | 39% ± 19% | |
ependymal cell | 3 studies | 31% ± 9% | |
mucus secreting cell | 3 studies | 24% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 897.66 | 459 / 459 | 100% | 13.99 | 1118 / 1118 |
intestine | 100% | 647.89 | 966 / 966 | 100% | 14.99 | 527 / 527 |
ovary | 100% | 669.27 | 180 / 180 | 100% | 11.79 | 430 / 430 |
stomach | 100% | 514.67 | 359 / 359 | 100% | 14.40 | 286 / 286 |
esophagus | 100% | 665.60 | 1444 / 1445 | 100% | 13.71 | 183 / 183 |
bladder | 100% | 690.10 | 21 / 21 | 100% | 13.86 | 503 / 504 |
lung | 100% | 807.68 | 577 / 578 | 100% | 14.13 | 1154 / 1155 |
prostate | 100% | 736.98 | 245 / 245 | 99% | 11.57 | 499 / 502 |
uterus | 100% | 816.75 | 170 / 170 | 99% | 13.27 | 456 / 459 |
pancreas | 100% | 448.67 | 327 / 328 | 99% | 13.35 | 177 / 178 |
thymus | 100% | 862.30 | 653 / 653 | 99% | 13.88 | 599 / 605 |
kidney | 100% | 590.45 | 89 / 89 | 98% | 10.14 | 887 / 901 |
skin | 100% | 670.87 | 1809 / 1809 | 97% | 12.47 | 459 / 472 |
adrenal gland | 100% | 502.80 | 258 / 258 | 96% | 8.64 | 221 / 230 |
brain | 93% | 378.15 | 2445 / 2642 | 100% | 8.62 | 704 / 705 |
liver | 100% | 306.55 | 225 / 226 | 90% | 5.75 | 365 / 406 |
adipose | 100% | 841.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2381.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.48 | 29 / 29 |
spleen | 100% | 650.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.46 | 1 / 1 |
heart | 93% | 359.52 | 800 / 861 | 0% | 0 | 0 / 0 |
muscle | 86% | 213.62 | 687 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 5.28 | 66 / 80 |
peripheral blood | 35% | 195.63 | 327 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0040029 | Biological process | epigenetic regulation of gene expression |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0006508 | Biological process | proteolysis |
GO_0051604 | Biological process | protein maturation |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042802 | Molecular function | identical protein binding |
GO_0004298 | Molecular function | threonine-type endopeptidase activity |
Gene name | TASP1 |
Protein name | Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta] Taspase 1 |
Synonyms | C20orf13 |
Description | FUNCTION: Protease responsible for KMT2A/MLL1 processing and activation . It also activates KMT2D/MLL2 (By similarity). Through substrate activation, it controls the expression of HOXA genes, and the expression of key cell cycle regulators including CCNA1, CCNB1, CCNE1 and CDKN2A (By similarity) . . |
Accessions | Q5JWM4 H7BZ38 ENST00000434275.1 ENST00000455532.5 ENST00000337743.9 [Q9H6P5-1] Q9H6P5 |